Half and Half Emergency Medicine X-Waiver Training
How it Works: This newly approved ED-specific training will provide 4 hours of online education followed by 4 hours of online directed self-study to be completed within 90 days.
Register for this FREE virtual training session and garner experience from experts in the field. You can take the online self-directed portion of the training after the session.
When you have completed the free course, you will be credentialed to apply for your DATA 2000 (X) waiver and prepared to manage OUD patients. Residents and students may also take this course so they are ready to apply for the waiver upon graduation.
Sponsoring Organization: www.pcssNOW.org
AAAP is the DATA 2000 sponsor for this training.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Tuesday, Dec. 6: 12:00 PM - 4:00 PM Central
A 4-hour Live Virtual Training Session
-
Gail D'Onofrio, MD, MS
Yale School of Medicine
-
Kathryn Hawk, MD, MHS
Yale School of Medicine
Kathryn Hawk, MD, MHS is an attending physician in the Yale New Haven Hospital Emergency Department and an Associate Professor in the Department of Emergency Medicine, the Yale School of Public Health and the Program in Addiction Medicine. She was a National Institute on Drug Abuse (NIDA) K12 sponsored Drug use, Addiction and HIV Research (DAHRS) Scholar, and is board certified in emergency and addiction medicine. She completed her residency training and research fellowship in the Yale University Department of Emergency Medicine. Her research primarily focuses on the design, testing and implementation of evidence based-care for ED patients with substance use disorders, with an emphasis on initiating medications for opioid and alcohol use disorder in the ED and maximizing effective linkage to ongoing treatment using innovative strategies. Her research on quality improvement and reducing opioid-associated mortality through data linkages, implementation-facilitation ED-initiated buprenorphine for opioid use disorder, initiating treatment for alcohol use disorder in the ED and the dissemination of evidence-based best practices for care of patients with addiction has been funded by NIDA, the Centers for Disease Control and Prevention (CDC), Emergency Medicine Foundation (EMF), Foundation for Opioid Response (FORE), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).